We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

By LabMedica International staff writers
Posted on 13 Oct 2026

Long Covid can involve persistent respiratory, cognitive, and gastrointestinal symptoms after acute infection, creating a difficult diagnostic and management challenge. More...

Because COVID-19 initially affects the respiratory tract, the airway microbiome may offer clues beyond previously observed gut microbiome changes. New findings now show distinct oral and lung microbiome patterns in people with the most severe long Covid symptoms.

The University of Dundee led the PHOSP-COVID research, which examined microbiome differences in people previously hospitalized with COVID-19. The study used DNA sequencing-based microbiome analysis of saliva and sputum samples to identify microbes present in the mouth and lungs. PHOSP-COVID is continuing to investigate the burden and management of long Covid.

The research included 771 people treated for COVID-19 between February 2020 and March 2021 at one of 38 UK hospitals. Participants were divided into four groups based on symptom severity five months after hospital discharge: very severe, severe, moderate, and mild. Six months after discharge, researchers collected saliva samples from the mouth and sputum samples from the lungs, then compared microbial variety and quantity with patient symptoms.

People with very severe long Covid showed clear differences in the microbiome of both the mouth and lungs compared with those without severe long Covid. The differences were linked to reduced lung function, neurocognitive symptoms including brain fog and problems with memory, attention, and concentration, and gastrointestinal symptoms including pain, nausea, diarrhea, and loss of appetite. An overabundance of lactic acid-producing bacteria was also associated with long Covid symptoms and with signs of inflammation in blood samples.

The findings were published in the European Respiratory Journal on October 11, 2026. The researchers noted that it remains unclear whether the microbiome changes existed before COVID-19 infection or developed afterward. They also stated that further work is needed to understand whether these microbiome changes improve over time and whether they could inform future treatment studies.

“What we don’t know is whether these changes came before a Covid infection, or whether the changes happened following a Covid infection. We also do not know what will happen to the microbiome in patients in subsequent years. We would love to know whether these changes get better with time,” said Professor James Chalmers, Chair of Respiratory Research at the University of Dundee.

Related Links
University of Dundee


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researcher Joris Deelen (Photo courtesy of Elton Alisson/Agência FAPESP)

Blood-Based Score May Support Targeted Interventions for Healthier Aging

Chronic diseases frequently accumulate with age, complicating efforts to maintain functional independence in older adults. Studies cited by the investigators indicate that about 60% of people over age... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.